海马保护技术在全脑放疗中的剂量学研究及认知功能观察
本文选题:全脑放疗 切入点:海马保护 出处:《郑州大学》2017年硕士论文 论文类型:学位论文
【摘要】:背景与目的脑转移瘤(Brain metastases,BM)是成人最常见的颅脑肿瘤,发病率接近于10/10万。BM的实际发病率可能比文献中报道出来的还要高,其数量与日俱增。恶性肿瘤进展到BM多提示预后不良,其头痛、头晕、恶心、呕吐、乏力等症状严重降低患者生存质量。全脑放疗(Whole-brain radiotherapy,WBRT)是BM的标准治疗方式之一,其临床应用仍在迅速发展。WBRT后导致的神经认知功能(Neurocognitive function,NCF)损伤逐渐引起临床重视。大量临床前研究显示,NCF的减退与放疗后海马(Hippocampal,HP)损伤有关。海马保护性全脑放疗(Hippocampal-sparing whole-brain radiotherapy,HS-WBRT)可以保护HP,从而避免NCF障碍。螺旋断层放射治疗(Helical tomotherapy,TOMO)的发展使HS-WBRT成为可能,避免BM患者在放疗后出现NCF的损伤。本研究将BM患者分为两组:WBRT组,用传统三维适形放疗(Three dimensional conformal radiotherapy,3D-CRT)两野对穿,不保护HP;HS-WBRT组,用TOMO技术保护HP。统计两组计划的参数及放疗后的NCF评分,通过对比来探讨海马保护技术在WBRT中的可行性,以及保护HP能够减轻放疗后的NCF损伤的可能性。方法选取郑州大学第一附属医院2015年8月至2016年8月期间收治的43例BM患者为研究对象,22例行WBRT;另外21例行HS-WBRT。统计两组的计划参数数值及NCF评分。采用SPSS 21.0软件对数据进行统计学处理:两组计划之间的剂量学、NCF评分对比:用W检验法(Shapiro-Wilk,W test)检验两组数据的正态性,Levene法检验方差齐性:第一,两组数据均服从正态分布,且符合方差齐性,则应用t检验;第二,两组数据服从正态分布,但方差不齐时,用矫正的t检验,即?检验;两组数据不服从正态分布时,采用Wilcoxon秩和检验。组内治疗前后NCF评分对比:数据符合正态性、方差齐性,用配对t检验;否则应用秩和检验。检验标准:P0.05为差异有统计学意义。结果两组之间计划靶区体积(Planning target volume,PTV)的比较,无统计学意义(P0.05);HI比较:3D-CRT组、TOMO组分别为0.12±0.02、0.36±0.03,对比有统计学意义(P0.05),3D-CRT在靶区剂量均匀性上优于TOMO。两组之间Dmean(左HP P=0.00;左HP P=0.00)和D max(左HP P=0.00;左HP P=0.00)的比较,具有统计学意义(P0.05);在HP受量上TOMO明显小于3D-CRT组,左HP的Dmean、Dmax分别降至处方剂量的20.14%、35.39%,右HP的Dmean、Dmax降至降至处方剂量的19.92%、35.14%。NCF评分对比结果:两组治疗前和治疗后1个月的NCF评分的比较均无统计学意义(P0.05);两组间治疗后3个月和治疗后6个月的对比有统计学意义(P0.05)。TOMO组,治疗前与治疗后比较差异无统计学意义(P0.05);3D-CRT组,治疗前和治疗后1个月的比较差异无统计学意义(P0.05);治疗前和治疗后3个月、治疗后6个月的NCF评分对比有统计学意义(P0.05)。TOMO组NCF评分优于3D-CRT组。未观察到3级及以上毒副反应。结论HS-WBRT治疗BM是可行的。TOMO能降低HP受量,在一定程度上避免NCF受损;但是在HI上,与3D-CRT相比,TOMO并无优势。
[Abstract]:Background and objective brain metastases (brain metastases) are the most common craniocerebral tumors in adults. The actual incidence of brain tumors close to 10/10 million BM may be higher than that reported in the literature. The number of brain metastases is increasing. The progression of malignant tumors to BM indicates poor prognosis. The symptoms of headache, dizziness, nausea, vomiting, fatigue and other symptoms seriously reduce the quality of life of patients. Whole-brain radiation therapy is one of the standard treatments for BM. Its clinical application is still developing rapidly. The neurocognitive function NCFs induced by WBRT have attracted more and more attention. A large number of preclinical studies have shown that the decrease of NCF is related to Hippocampal HPP damage after radiotherapy. Hippocampal-sparing is associated with Hippocampal-sparing. HS-WBRT) can protect whole-brain from NCF disorders. The development of helical radiation therapy makes HS-WBRT possible. In this study, BM patients were divided into two groups: WBRT group. Conventional three-dimensional conformal radiotherapy was used to treat with three dimensional conformal radiotherapytic 3D-CRTRT without protecting HPS-WBRT. The TOMO technique was used to protect HP. the parameters of the two groups and the NCF scores after radiotherapy were counted, and the feasibility of hippocampal protection in WBRT was discussed by comparison. Methods 43 patients with BM admitted from August 2015 to August 2016 in the first affiliated Hospital of Zhengzhou University were selected as study subjects: 22 patients were treated with NCF and 21 patients were treated with HS-WBRT.These patients were treated with HS-WBRT.Methods from August 2015 to August 2016, 43 patients with BM were selected as study subjects, 22 with WBRT and 21 with HS-WBRT. Taking into account the planned parameter values and NCF scores of the two groups. The data were processed statistically with SPSS 21.0 software. The dosimetry scores of the two groups were compared. The normal Levene method was used to test the homogeneity of variance between the two groups of data by using the W test method. If both groups of data are subject to normal distribution and conformance to homogeneity of variance, t test is applied. Second, when two groups of data take normal distribution, but the variance is uneven, the corrected t test is used, that is? Wilcoxon rank sum test was used when the two groups of data were not subject to normal distribution. The NCF scores before and after treatment were compared: the data were consistent with normality and homogeneity of variance, and matched t test was used. Otherwise, the rank sum test was used. The test standard: 0. 05 was statistically significant. Results the planned target volume target volume PTV was compared between the two groups. No statistical significance was found in the HI comparison between the TOMO group and the 3D-CRT group (0.12 卤0.02 卤0.36 卤0.03, respectively). The comparison between the two groups in the dose uniformity of the target area was better than that of TOMO.The Dmean (left HP P0. 00; left HP P0. 00) and D max( left HP P0. 00C; left HP P0. 00C) were compared between the two groups. The TOMO of HP was significantly lower than that of 3D-CRT group. Dmean Dmax of left HP decreased to 20.14 ~ 35.39 of prescription dose, Dmean Dmax of right HP decreased to 19.92 ~ 35.14% of prescription dose: there was no significant difference in NCF score between two groups before treatment and one month after treatment (P 0.05). There were significant differences between months after treatment and 6 months after treatment in the TOMO group. There was no significant difference before and after treatment in P0.05D CRT group, there was no significant difference before treatment and 1 month after treatment, there was no significant difference before and after treatment, and there was no significant difference before treatment and 3 months after treatment. Six months after treatment, there was significant difference in the NCF score between the two groups. The NCF score of the tomo group was better than that of the 3D-CRT group. No toxic and adverse reactions were observed in the 3rd grade group or above. Conclusion HS-WBRT treatment with BM can reduce the level of HP and avoid NCF damage to a certain extent. In HI, however, TOMO has no advantage over 3 D-CRT.
【学位授予单位】:郑州大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R739.4;R730.55
【相似文献】
相关期刊论文 前10条
1 王远驰;王洪源;;短程全脑放疗在非小细胞肺癌脑转移病人中的疗效观察[J];临床肺科杂志;2008年04期
2 侯艳丽;白永瑞;朱义文;曹鸿斌;荣玲;黄仁华;;全脑放疗与联合立体定向外科治疗非小细胞肺癌脑转移60例[J];中国肿瘤;2007年12期
3 周荻;徐欣;谢华英;马秀梅;白永瑞;;全脑放疗联合靶向治疗与同步放、化疗治疗非小细胞肺癌脑转移疗效分析[J];上海交通大学学报(医学版);2013年04期
4 朱向满;谢云科;王帅;;替尼泊甙联合全脑放疗治疗脑转移癌的临床研究[J];河北医药;2009年14期
5 林宇;;全脑放疗结合后程γ射线立体定向放射治疗48例肺癌多发脑转移的临床分析[J];立体定向和功能性神经外科杂志;2013年03期
6 郭宇玲;李丽芳;徐丽瑶;蔡阿桥;李勇;;全脑放疗联合伊立替康治疗非小细胞肺癌脑转移的Ⅰ期临床试验研究[J];中国全科医学;2014年21期
7 郑爱青;郑蓓;邹忠材;郭雄芳;穆海玉;梁克明;;头部伽玛刀加全脑放疗治疗非小细胞肺癌脑转移瘤疗效观察[J];解放军医学杂志;2009年06期
8 张清琴;岳军艳;寇小格;崔艳慧;李小瑞;;老年脑转移瘤患者短程全脑放疗的效果及预后因素[J];中国老年学杂志;2012年11期
9 魏光楠;;恶性肿瘤脑转移全脑放疗的护理[J];中华护理杂志;1989年11期
10 王希成,杨曙,王新宁,刘魁凤,庄承海;全脑放疗加伽玛刀治疗非小细胞肺癌多发脑转移的临床研究[J];实用医学杂志;2005年04期
相关会议论文 前10条
1 朱广迎;石安辉;余荣;马惠民;刘长青;苏星;孙艳;蔡勇;徐晓娜;张珊文;徐博;;有症状的非小细胞肺癌脑转移应早做全脑放疗[A];第四届中国肿瘤学术大会暨第五届海峡两岸肿瘤学术会议论文集[C];2006年
2 周麟;刘佳;刘咏梅;徐庆丰;蒋晓琴;柏森;卢铀;;全脑放疗配合图像引导局部调强治疗非小细胞肺癌脑转移的临床Ⅰ期研究[A];2007第六届全国放射肿瘤学学术年会论文集[C];2007年
3 戴晓波;;脑原发性恶性淋巴瘤2例报告及文献复习[A];2000全国肿瘤学术大会论文集[C];2000年
4 牛中奇;;生物电磁剂量学概论[A];全国非电离辐射与电离辐射生物效应及防护学术研讨会论文汇编[C];2004年
5 牛中奇;;电磁波生物学效应研究中的电磁剂量学概述[A];中国科协2005年学术年会生物物理与重大疾病分会论文摘要集[C];2005年
6 牛中奇;周永军;侯建强;陈建华;王海彬;童颖;;射频电磁场的生物电磁剂量学[A];第十次中国生物物理学术大会论文摘要集[C];2006年
7 任江平;;剂量学射野误差影响因素的研究[A];2009年浙江省放射肿瘤治疗学学术年会论文汇编[C];2009年
8 牛中奇;尹媛媛;黄华;韩磊;刘先超;刘菲;董英华;薛佩佩;;生物电磁剂量学的数值分析[A];中国生物医学工程进展——2007中国生物医学工程联合学术年会论文集(下册)[C];2007年
9 侯长松;程玉玺;王建华;秦文华;乔红兵;;旧CT机的剂量学评价[A];中华医学会放射医学与防护学分会第三次全国中青年学术交流会论文汇编[C];2001年
10 李开宝;罗素明;何志坚;朱卫国;程金生;郭朝辉;;放射治疗剂量学邮寄TLD质量核查技术研究进展[A];21世纪初辐射防护论坛第五次会议论文集[C];2006年
相关博士学位论文 前1条
1 于淼;慢性缺陷型精神分裂症患者神经认知与基于静息态功能磁共振的神经影像学研究[D];东南大学;2016年
相关硕士学位论文 前10条
1 蒲廷;替莫唑胺联合全脑放疗治疗非小细肺癌脑转移的系统评价[D];四川医科大学;2015年
2 申东星;全脑放疗与否及不同剂量对肺癌脑转移生存影响[D];河北医科大学;2017年
3 申晓菲;全脑放疗与否及剂量对乳腺癌脑转移的生存影响分析[D];河北医科大学;2017年
4 金福军;全脑放疗联合靶向药物与单独全脑放疗治疗非小细胞肺癌脑转移疗效及安全性的Meta分析[D];重庆医科大学;2017年
5 冯娟;112例非小细胞肺癌脑转移的治疗与预后分析[D];大连医科大学;2014年
6 赵送会;4D-CT技术在肺癌放射治疗靶区勾画中的应用及几何学和剂量学研究[D];昆明医科大学;2015年
7 刘培培;容积旋转调强放疗技术在宫颈癌放射治疗中的剂量学研究[D];天津医科大学;2015年
8 郑倩倩;基于EPID的IGRT剂量学质量控制研究[D];中国疾病预防控制中心;2017年
9 郝丽云;替莫唑胺同步放疗治疗脑转移瘤的临床研究[D];延安大学;2017年
10 郭晓杰;重性抑郁障碍和儿童期虐待对成人神经认知功能影响研究[D];山西医科大学;2016年
,本文编号:1634123
本文链接:https://www.wllwen.com/yixuelunwen/fangshe/1634123.html